Vivos (RDGL) EBT Growth (5y) (2015 - 2025)
Vivos (RDGL) EBT Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.99% |
| Sep 30, 2025 | -30.20% |
| Jun 30, 2025 | -32.33% |
| Mar 31, 2025 | -18.30% |
| Dec 31, 2024 | -15.21% |
| Sep 30, 2024 | -4.28% |
| Jun 30, 2024 | -20.24% |
| Mar 31, 2024 | -18.76% |
| Dec 31, 2023 | -15.34% |
| Sep 30, 2023 | 52.26% |
| Jun 30, 2023 | 31.56% |
| Mar 31, 2023 | 22.73% |
| Dec 31, 2022 | 23.10% |
| Sep 30, 2022 | 31.66% |
| Jun 30, 2022 | 12.31% |
| Mar 31, 2022 | -10.92% |
| Dec 31, 2021 | -21.20% |
| Sep 30, 2021 | -5.22% |
| Jun 30, 2021 | 14.96% |
| Mar 31, 2021 | 45.15% |